Biomaterial regulation of excessive inflammation restores osteoimmune homeostasis in diabetic bone regeneration
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 10.03.2026. Verfasst von Qiyue Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu 210008, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Sciences Foundation of China, Natural Science Foundation of Jiangsu Province, Nanjing Science and Technique Development Foundation.
Abstract (Originalsprache)
Diabetes mellitus markedly increases the incidence of fractures, implant failure and nonunion, primarily because chronic low-grade inflammation and a disrupted bone microenvironment impair regeneration. Under physiological conditions, coordinated interactions among immune, stromal, vascular and neural cells ensure timely initiation and resolution of inflammation, thereby maintaining osteoimmune homeostasis and supporting bone repair. In diabetes, hyperglycemia-induced oxidative stress, advanced glycation end products, impaired vascularization and ‘inflammatory memory’ prolong and intensify inflammatory responses. This excessive and unresolved inflammation disturbs immune–bone crosstalk, alters macrophage and T-cell phenotypes and uncouples osteogenesis and angiogenesis, ultimately hindering bone regeneration. This review summarizes the cellular and molecular basis of osteoimmune homeostasis and outlines how diabetes disrupts this regulatory network at systemic and local levels. We further highlight biomaterial strategies designed to modulate excessive inflammation and restore osteoimmune balance in diabetic bone regeneration, including localized delivery systems, cell-derived and extracellular vesicle-based agents, nanozyme-mediated microenvironmental regulation and immune-instructive physicochemical biomaterials. Finally, we discuss the critical hurdles of clinical translation (e.g. standardized scalable fabrication and long-term biosafety) and highlight multifactor integrated, logic-gated designs and systemic diabetes management strategies for advancing next-generation biomaterials for diabetic bone regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu 210008, China.
- Institute for Health Innovation and Technology, Biomedical Engineering Department, National University of Singapore, Singapore 119276, Singapore.
- Department of Oral Implantology, Suzhou doctor dental clinic Co. LTD, Suzhou 215000, China.
ORCID-Profile: Yu Zhang, Qiang Li, Weijun Xiu, Yongbin Mou, Heng Dong
Förderung
- National Natural Sciences Foundation of China
- Natural Science Foundation of Jiangsu Province
- Nanjing Science and Technique Development Foundation
- Jiangsu Association for Science and Technology (JAST) Young Talents Lift-up Program
- Nanjing Medical Science and Technique Development Foundation
Zitieren
APA
Zhou, Q., Zhang, Y., Dai, Z., Li, Q., Xiu, W., Lv, H., Mou, Y., & Dong, H. (2026). Biomaterial regulation of excessive inflammation restores osteoimmune homeostasis in diabetic bone regeneration. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag055
Vancouver
Zhou Q, Zhang Y, Dai Z, Li Q, Xiu W, Lv H, et al. Biomaterial regulation of excessive inflammation restores osteoimmune homeostasis in diabetic bone regeneration. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag055
BibTeX
@article{Zhou2026,
author = {Zhou, Qiyue and Zhang, Yu and Dai, Zhuo and Li, Qiang and Xiu, Weijun and Lv, Haoxin and Mou, Yongbin and Dong, Heng},
title = {Biomaterial regulation of excessive inflammation restores osteoimmune homeostasis in diabetic bone regeneration},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag055}
}
EUVIMED